Phase II clinical studies of UTD1, an epothilone analog, in metastatic breast cancer.
Binghe Xu
No relevant relationships to disclose
Pin Zhang
No relevant relationships to disclose
Zhongsheng Tong
No relevant relationships to disclose
Fuguo Tian
No relevant relationships to disclose
Yongsheng Wang
No relevant relationships to disclose
Jun Lan Yang
No relevant relationships to disclose
Lijun Di
No relevant relationships to disclose
Weilian Li
No relevant relationships to disclose
Wei Liu
No relevant relationships to disclose
Rongguo Qiu
No relevant relationships to disclose
Li Tang
No relevant relationships to disclose